ASCML
OGEN icon

ADKINS SEALE CAPITAL MANAGEMENT LLC’s Oragenics OGEN Stock Holding History

ADKINS SEALE CAPITAL MANAGEMENT LLC’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2 Hold
3
– – ﹤0.01% 236
2026
Q1 		$2 Hold
3
– – ﹤0.01% 227
2025
Q4 		$2 Buy
+3
New +$3 ﹤0.01% 226

Other funds holding OGEN

2L
25 LLC St. Louis, Missouri $365M AUM 18.53% 1-Year Est. Return
SJIM
St. Johns Investment Management Jacksonville, Florida $264M AUM 29.48% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
BWL
Bogart Wealth LLC Mclean, Virginia $2.92B AUM 23.85% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

ADKINS SEALE CAPITAL MANAGEMENT LLC's OGEN Position: Q2 2026 in Review

ADKINS SEALE CAPITAL MANAGEMENT LLC held its Oragenics (OGEN) position steady in Q2 2026 at 3 shares worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #236.

ADKINS SEALE CAPITAL MANAGEMENT LLC first reported a position in OGEN in Q4 2025 and has held it in 3 quarters since. 6 funds tracked by Wall St. Rank hold OGEN as of Q2 2026.

  • ADKINS SEALE CAPITAL MANAGEMENT LLC held 3 shares of Oragenics worth $2 as of Q2 2026.
  • ADKINS SEALE CAPITAL MANAGEMENT LLC left its Oragenics share count unchanged in Q2 2026.
  • Oragenics made up ﹤0.01% of ADKINS SEALE CAPITAL MANAGEMENT LLC's portfolio in Q2 2026, its #236 holding.
  • ADKINS SEALE CAPITAL MANAGEMENT LLC first reported a position in Oragenics in Q4 2025 and has held it in 3 quarters since.
  • 6 funds tracked by Wall St. Rank held Oragenics as of Q2 2026.

Based on ADKINS SEALE CAPITAL MANAGEMENT LLC's 13F filing for Q2 2026, filed 5 Aug 2026.